Factors Associated with Increasing Costs in Severe Chronic Obstructive Pulmonary Disease Exacerbation: Turkish Thoracic Society Chronic Obstructive Pulmonary Disease Assembly.

Autor:	Baha A; Department of Chest Diseases, Girne American University Faculty of Medicine, Girne, Turkish Republic of Northern Cyprus.; Department of Chest Diseases, Girne Doctor Akçiçek State Hospital, Girne, Turkish Republic of Northern Cyprus., Köktürk N; Department of Chest Diseases, Faculty of Medicine, Gazi University, Ankara, Turkey., Baysan C; Department of Public Health/Epidemiology, İzmir Democracy University Faculty of Medicine, İzmir, Turkey., Öztürk B; Department of Chest Diseases, 25 Aralık State Hospital, Gaziantep, Turkey., Cengiz SK; Department of Chest Diseases, Kartal Lütfi Kırdar Traning and Research Hospital, İstanbul, Turkey., Varol Y; Department of Chest Diseases, Dr. Suat Seren Chest Diseases and Chest Surgery Traning and Research Hospital, İzmir Health Sciences University, İzmir, Turkey., Mertoğlu A; Department of Chest Diseases, Dr. Suat Seren Chest Diseases and Chest Surgery Traning and Research Hospital, İzmir Health Sciences University, İzmir, Turkey., Çırak AK; Department of Chest Diseases, Dr. Suat Seren Chest Diseases and Chest Surgery Traning and Research Hospital, İzmir Health Sciences University, İzmir, Turkey., Turan O; Department of Chest Diseases, İzmir Katip Çelebi University Faculty of Medicine, İzmir, Turkey., Dursunoğlu N; Department of Chest Diseases, Pamukkale University Faculty of Medicine, Denizli, Turkey., Savurmuş N; Department of Chest Diseases, Burdur State Hospital, Burdur, Turkey., Gürgün A; Department of Chest Diseases, Ege University Faculty of Medicine, İzmir, Turkey., Elmas F; Department of Chest Diseases, Ege University Faculty of Medicine, İzmir, Turkey., Çöplü L; Department of Chest Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey., Sertçelik Ü; Department of Chest Diseases, Ankara City Hospital, Ministry of Health University, Ankara, Turkey., Yıldız R; Department of Chest Diseases, Süreyyapaşa Chest Diseases and Chest Surgery Traning and Research Hospital, İstanbul, Turkey., İpek Ö; Department of Chest Diseases, Süreyyapaşa Chest Diseases and Chest Surgery Traning and Research Hospital, İstanbul, Turkey., Alpaydın AÖ; Department of Pulmonary Diseases, Dokuz Eylül University School of Medicine, İzmir, Turkey.
Jazyk:	angličtina
Zdroj:	Thoracic research and practice [Thorac Res Pract] 2024 Jan 03; Vol. 25 (1), pp. 17-25.
DOI:	10.5152/ThoracResPract.2024.23065
Abstrakt:	Chronic obstructive pulmonary disease (COPD) that is the third leading cause of death in the world is one of the main economic burden. The cost is primarily due to COPD exacerbations and hospitalizations. We aimed to determine the factors associated with increasing costs in severe COPD exacerbation. It was a multicenter and prospective observational recording study. 294 patients who severe COPD exacerbation were included in the study. An amount of more than 429.58 euros was accepted as increasing costs (IC). Factors associated with IC were determined by regression analysis. Mean age was 69.90 ± 9.79/years (minimum: 40 maximum: 95), mean costs were 594.9 ± 70.9 euros. About 83.7% of the patients were male, 24.1% (71) were active smokers, and 81% (238) had at least 1 comorbidity. Factors associated with IC in the regression analysis were delay of discharge (due to prolonged consultation), antibiotic use longer than 7 days, need to enteral/parenteral feeding, application of pulmonary rehabilitation (physiotherapy) at hospitalization, and refusal to be discharged. The increasing costs in severe COPD exacerbation depends not only treatment but also the patient's social status and hospital-related factors. We think that the cost of severe COPD exacerbation can be reduced by interventions on interchangeable factors such as patient's social status and hospital-related factors.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu PDF